Mark Lingen to Drug Synergism
This is a "connection" page, showing publications Mark Lingen has written about Drug Synergism.
Connection Strength
0.102
-
Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling. Cancer Res. 2002 Dec 15; 62(24):7143-8.
Score: 0.047
-
Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res. 1998 Dec 01; 58(23):5551-8.
Score: 0.035
-
Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin. Head Neck. 2011 Dec; 33(12):1774-82.
Score: 0.021